AU Patent

AU2014312086B2 — Antibodies and assays for detection of folate receptor 1

Assigned to Immunogen Inc · Expires 2020-03-12 · 6y expired

What this patent protects

The invention generally relates to antibodies that bind to human folate receptor and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.

USPTO Abstract

The invention generally relates to antibodies that bind to human folate receptor and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014312086B2
Jurisdiction
AU
Classification
—
Expires
2020-03-12
Drug substance claim
No
Drug product claim
No
Assignee
Immunogen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.